Cargando…
UCP2 induces metabolic reprogramming to inhibit proliferation of cancer cells
Invalidation of uncoupling protein 2 (Ucp2) increases glucose utilization and proliferation in normal cells. We recently reported that cancer cells that overexpress UCP2 become less tumorigenic while switching their metabolism from glycolysis to oxidative phosphorylation. UCP2 appears to be a key re...
Autores principales: | Esteves, Pauline, Pecqueur, Claire, Alves-Guerra, Marie-Clotilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905249/ https://www.ncbi.nlm.nih.gov/pubmed/27308391 http://dx.doi.org/10.4161/23723556.2014.975024 |
Ejemplares similares
-
UCP2 silencing restrains leukemia cell proliferation through glutamine metabolic remodeling
por: Sancerni, Tiphaine, et al.
Publicado: (2022) -
FLCN: A new regulator of AMPK-dependent Warburg metabolic reprogramming
por: Gingras, Marie-Claude, et al.
Publicado: (2014) -
ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer
por: Mishra, Prachi, et al.
Publicado: (2018) -
UCP2 Deficiency Increases Colon Tumorigenesis by Promoting Lipid Synthesis and Depleting NADPH for Antioxidant Defenses
por: Aguilar, Esther, et al.
Publicado: (2019) -
The metabolic reprogramming and vulnerability of SF3B1 mutations
por: Dalton, W. Brian
Publicado: (2020)